Abstract
Hepatocellular carcinoma (HCC) is the sixth most common cause of death worldwide and the main cause of primary liver cancer. The principle problem of HCC is the poor prognosis, since advanced HCC reportedly has a median survival of only 9 months. The standard therapies are sorafenib and regorafenib, but the outcomes remain unclear. We report a 60-year-old man with advanced HCC with right adrenal gland metastasis and portal vein tumor thrombosis, who showed a complete response to multiple applications of an interdisciplinary therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 424-429 |
| Number of pages | 6 |
| Journal | Clinical and molecular hepatology |
| Volume | 24 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1 Dec 2018 |
| Externally published | Yes |
Keywords
- Adrenal gland
- Hepatocellular carcinoma
- Portal vein thrombosis